MLYS Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Mineralys Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 14.65 USD 3.39%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast MLYS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLYS is 34.51 USD with a low forecast of 27.27 USD and a high forecast of 47.25 USD.

MLYS Lowest Forecast

Wall Street Target

MLYS Average Forecast

Wall Street Target

MLYS Highest Forecast

Wall Street Target

86% Upside

136% Upside

223% Upside

The latest public price target was made on Apr 2, 2024 by Richard Law from Goldman Sachs , who expects MLYS stock to rise by 105% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Richard Law Goldman Sachs	30 USD Upside 105%	1 month ago Apr 2, 2024	Goldman Sachs Starts Mineralys Therapeutics, Inc. (MLYS) at Buy, 'Upcoming Pivotal Results Could Surprise on the Upside' StreetInsider

Price Target	30 USD
Upside/Downside	105%

Exscientia PLC

92% Upside

iNtRON Biotechnology Inc

143% Upside

Caribou Biosciences Inc

483% Upside

Bloomage Biotechnology Corp Ltd

16% Upside

Exscientia PLC

92% Upside

iNtRON Biotechnology Inc

143% Upside

Caribou Biosciences Inc

483% Upside

Bloomage Biotechnology Corp Ltd

16% Upside

Anika Therapeutics Inc

9% Upside

Suzhou Zelgen Biopharmaceuticals Co Ltd

7% Upside

EuBiologics Co Ltd

9% Upside

Deciphera Pharmaceuticals Inc

7% Upside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Net Income
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for MLYS is 34.51 USD with a low forecast of 27.27 USD and a high forecast of 47.25 USD.

Join more than 135,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.